Octavio Espinoza
Chief Financial Officer at Ligand Pharmaceuticals. Based in Jupiter, Florida.
- Rank
- 10427th of 14,452
- Companies held
- 1
- Largest holding
- LGND, 100.0% of total
- Latest SEC filing
- Aug 12, 2026
What the $7.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals LGND Common Stock | Directly | 27,696 | $286.94 | $7.9M | 100.0% | Form 4, Aug 12, 2026 |
Share counts are the amounts Octavio Espinoza reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Sold | LGND | 31,641 | $292.07 | $9.2M | View |
| Mar 11, 2026 | Sold | LGND | 3,057 | $225.00 | $688K | View |
| Mar 4, 2026 | Sold | LGND | 950 | $201.73 | $192K | View |
| Mar 4, 2026 | Sold | LGND | 3,413 | $208.80 | $713K | View |
| Mar 4, 2026 | Sold | LGND | 2,457 | $207.91 | $511K | View |
| Mar 4, 2026 | Sold | LGND | 699 | $198.71 | $139K | View |
| Mar 4, 2026 | Sold | LGND | 53 | $200.08 | $11K | View |
| Mar 4, 2026 | Sold | LGND | 698 | $201.09 | $140K | View |
| Mar 4, 2026 | Sold | LGND | 697 | $202.79 | $141K | View |
| Mar 4, 2026 | Sold | LGND | 668 | $203.63 | $136K | View |
| Mar 4, 2026 | Sold | LGND | 743 | $204.74 | $152K | View |
| Mar 4, 2026 | Sold | LGND | 1,457 | $205.79 | $300K | View |
| Mar 4, 2026 | Sold | LGND | 1,588 | $206.89 | $329K | View |
| Dec 12, 2025 | Sold | LGND | 1,804 | $188.31 | $340K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 10424 | Mary D. Petryszyn Corporate Vice President, Northrop Grumman. Fort Collins, CO | $8.0M |
| 10425 | Tse Meng Ng CEO and Chairman, RF Acquisition Corp II | $7.9M |
| 10426 | Deborah Guild Executive Vice President, The PNC Financial Services Group. Pittsburgh, PA | $7.9M |
| 10427 | Octavio Espinoza Chief Financial Officer, Ligand Pharmaceuticals. Jupiter, FL | $7.9M |
| 10428 | Carrie Strom SVP & PRES GLOBAL ALLERG AESTH, AbbVie. North Chicago, IL | $7.9M |
| 10429 | C. Michael Dozier EXECUTIVE VICE PRESIDENT, PACCAR. Bellevue, WA | $7.9M |
| 10430 | Christopher O. Champion VP, CAO and Controller, Occidental Petroleum. Houston, TX | $7.9M |
Other Ligand Pharmaceuticals insiders
All LGND insiders- John L. Higgins$120MDirector. #1162 overall
- Matthew W. Foehr$74.6MInsider. #1495 overall
- Todd C. Davis$57.2MChief Executive Officer. #1694 overall
- Jason Aryeh$31.7MDirector. #3496 overall
- Matthew E. Korenberg$14.6MPresident & COO. #6391 overall
- Sunil Patel$13.3MInsider. #6660 overall
Questions
How much stock does Octavio Espinoza own?
Octavio Espinoza holds $7,947,090 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 10427th on the Stock Rich List.
Is this Octavio Espinoza's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Octavio Espinoza last buy or sell stock?
The most recent open-market trade on file is a sale of 31,641 LGND shares on Aug 12, 2026 at $292.07.